Molecular Partners Ag annual operating margin
2019
2020
2021
2022
2023
2024
Molecular Partners Ag's operating margin was −1,231.73% for fiscal 2024.
View full Molecular Partners Ag company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −1,231.73% | −363.47 pp |
| 2023 | 2023-12-31 | −868.26% | −929.76 pp |
| 2022 | 2022-12-31 | 61.50% | +711.68 pp |
| 2021 | 2021-12-31 | −650.17% | −25.97 pp |
| 2020 | 2020-12-31 | −624.21% | −444.35 pp |
| 2019 | 2019-12-31 | −179.86% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −1,030.05% | — |
| Q2 2023 | 2023-06-30 | −3,827.23% | — |
| Q2 2022 | 2022-06-30 | −53.52% | — |
Over the last five reported fiscal years, Molecular Partners Ag's operating margin decreased from −179.86% to −1,231.73%, a change of −1051.87 percentage points. The latest reported quarter, Q2 2024, shows −1,030.05%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Molecular Partners Ag filings at SEC.gov ↗